Cardiovascular risk in Type 2 Diabetes

The risk of CVD mortality in type 2 diabetic patients is more than double compared with that in age-matched subjects. Stroke events and all manifestations of CHD, myocardial infarction (MI), sudden death, and angina pectoris is at least twofold more common in patients with type 2 diabetes than in non-diabetic individuals. A high proportion of patients with type 2 diabetes die after an acute MI within 1 year, and a considerable number of patients die outside the hospital. Relative risk for CHD events is higher in female patients with type 2 diabetes than in male patients with type 2 diabetes. The reason for the sex difference is largely unknown but could be at least in part explained by a heavier risk-factor burden and a greater effect of blood pressure and atherogenic dyslipidemia on the risk of CVD in diabetic women than in diabetic men.

The prognosis of patients with type 2 diabetes is highly dependent on the presence of CVD. We compared the 7-year incidence of fatal and nonfatal MI among 1,373 non-diabetic subjects with the incidence among 1,059 subjects with type 2 diabetes. Our study suggested that patients with type 2 diabetes without previous MI have as high a risk of MI as non-diabetic patients with previous MI. Thus, our results indicated that type 2 diabetes is a “coronary heart disease equivalent.” These results were recently replicated by an 18-year follow-up study of our original cohort and by a Danish study including 3.3 million subjects. One of the paradoxes in the studies of cardiovascular complications in type 2 diabetes is that at diagnosis individuals with type 2 diabetes already has substantially increased prevalence of CHD and stroke.

  • High Blood Pressure
  • Heart Disease
  • High Blood Glucose
  • Damage of Blood Vessels
  • Atherosclerosis and Hypertension
  • Shortness of Breath
  • Diabetic Neuropathy

Related Conference of Cardiovascular risk in Type 2 Diabetes

February 22-23, 2023

32nd European Diabetes Congress

Madrid, Spain
March 27-28, 2023

56th Annual Congress on Endocrinology & Disorders

Vancouver, Canada
April 18-19, 2023

Global Summit on Endocrinology

Madrid, Spain
April 18-19, 2023

European Endocrinology and Diabetes Congress

Madrid, Spain
April 20-21, 2023

6th Annual Meeting on Diabetes and Endocrinology

Barcelona, Spain
May 15-16, 2023

4th Global summit on Diabetes and Endocrinology

Madrid, Spain
June 05-06, 2023

World Congress on Endocrine and Diabetes

San Francisco, USA
June 15-16, 2023

4th Annual conference on Diabetes

San Francisco, USA
July 24-25, 2023

18th International Summit on Diabetes

Venice, Italy
August 10-11, 2023

25th World Congress on Diabetes and Endocrine Disorders

Dublin, Ireland
September 07-08, 2023

19th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
September 12-13, 2023

7th Annual Conference on Diabetes and Endocrinology

Barcelona, Spain
September 14-15, 2023

3rd Annual Summit on Diabetes and Endocrinology

Bangkok, Thailand
October 16-17, 2023

2nd World congress and Expo on Diabetes

Vancouver, Canada
October 21-22, 2023

4th World Summit on Diabetes Expo

New York, USA
November 20-21, 2023

17th European Diabetes and Endocrinology Congress

Dubai, UAE
November 27-28, 2023

27th International Conference on Diabetes, Endocrinology and Healthcare

Singapore City, Singapore

Cardiovascular risk in Type 2 Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in